Compare
ABUS · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
ABUS
Arbutus Biopharma Corp
4.11
+0.08 (1.89%)
Valuation
| Index | RUT |
|---|---|
| Market Cap | $629.47M |
| Enterprise Value | 295.29M |
| Income | 219.91M |
| Sales | 181.49M |
| Book / share | 0.43 |
| Cash / share | 2.20 |
| Dividend Gr. 3/5Y | - - |
| Employees | 19 |
| IPO | Jul 23, 2007 |
Ratios
| Price / earnings | 3.67 |
|---|---|
| Price / sales | 3.47 |
| Price / book | 9.54 |
| Price / cash | 1.87 |
| Value / cash profit | 2.03 |
| Value / sales | 1.63 |
| Quick Ratio | 1.40 |
| Current Ratio | 1.40 |
| Debt / equity | 0.04 |
| Long-term debt / equity | 0.03 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | 1.12 |
|---|---|
| Earnings next year | -0.08 |
| Earnings next quarter | -0.02 |
| Earnings this year | 535.29% |
| Past earnings growth | 27.58% 29.45% |
| Past sales growth | -28.80% 15.29% |
| Earnings vs last year | 608.48% |
| Sales vs last year | 1142.57% |
| Earnings vs last quarter | 832.92% |
| Sales vs last quarter | -43.48% |
| Earnings | Nov 10 BMO · 3 days ago |
| Surprise | 1393.10% -70.10% |
Ownership
| Insiders own | 20.55% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 65.27% |
| Institution trades | -6.31% |
| Return on assets | 100.55% |
| Return on equity | 269.59% |
| Return on capital | 247.85% |
| Gross Margin | 99.98% |
| Operating margin | 80.14% |
| Profit Margin | 121.17% |
| 20-day average | 1.05% |
| 50-day average | -7.96% |
| 200-day average | -8.36% |
Technical
| Shares out | 199.28M |
|---|---|
| Shares floating | 157.40M |
| Short / float | 12.64% |
| Short ratio | 3.92 |
| Short interest | 19.89M |
| 52-week high | 5.45 -24.7% |
| 52-week low | 3.50 +17.3% |
| Volatility | 5.62% 4.53% |
| Average range | 0.21 |
| Strength index | 49.10 |
| Market sensitivity | 0.81 |
| Relative volume | 0.01 |
| Avg Volume | 5.08M |
| Volume | 1,607 |
Performance
| Perf Week | 12.35% |
|---|---|
| Perf Month | -4.28% |
| Perf Quarter | -12.82% |
| Perf Half Y | -3.15% |
| Perf YTD | -14.63% |
| Perf Year | -9.95% |
| Perf 3Y | 129.40% |
| Perf 5Y | 18.34% |
| Perf 10Y | 46.65% |
| Recommendation | 1.00 |
| Target Price | 5.50 |
| Prev Close | 4.03 |
| Price | 4.11 |
| Change % | 1.89% |
Compare
| ABUS | |
|---|---|
| Price | 4.11 |
| Change | +0.08 (1.89%) |
Compare · Valuation
| ABUS | |
|---|---|
| Index | RUT |
| Market Cap | $629.47M |
| Enterprise Value | 295.29M |
| Income | 219.91M |
| Sales | 181.49M |
| Book / share | 0.43 |
| Cash / share | 2.20 |
| Dividend Gr. 3/5Y | - - |
| Employees | 19 |
| IPO | Jul 23, 2007 |
Compare · Ratios
| ABUS | |
|---|---|
| Price / earnings | 3.67 |
| Price / sales | 3.47 |
| Price / book | 9.54 |
| Price / cash | 1.87 |
| Value / cash profit | 2.03 |
| Value / sales | 1.63 |
| Quick Ratio | 1.40 |
| Current Ratio | 1.40 |
| Debt / equity | 0.04 |
| Long-term debt / equity | 0.03 |
| Options and short | Yes / Yes |
Compare · Earnings
| ABUS | |
|---|---|
| Earnings / share | 1.12 |
| Earnings next year | -0.08 |
| Earnings next quarter | -0.02 |
| Earnings this year | 535.29% |
| Past earnings growth | 27.58% 29.45% |
| Past sales growth | -28.80% 15.29% |
| Earnings vs last year | 608.48% |
| Sales vs last year | 1142.57% |
| Earnings vs last quarter | 832.92% |
| Sales vs last quarter | -43.48% |
| Earnings | Nov 10 BMO · 3 days ago |
| Surprise | 1393.10% -70.10% |
Compare · Ownership
| ABUS | |
|---|---|
| Insiders own | 20.55% |
| Insider trades | 0.00% |
| Institutions own | 65.27% |
| Institution trades | -6.31% |
| Return on assets | 100.55% |
| Return on equity | 269.59% |
| Return on capital | 247.85% |
| Gross Margin | 99.98% |
| Operating margin | 80.14% |
| Profit Margin | 121.17% |
| 20-day average | 1.05% |
| 50-day average | -7.96% |
| 200-day average | -8.36% |
Compare · Technical
| ABUS | |
|---|---|
| Shares out | 199.28M |
| Shares floating | 157.40M |
| Short / float | 12.64% |
| Short ratio | 3.92 |
| Short interest | 19.89M |
| 52-week high | 5.45 -24.7% |
| 52-week low | 3.50 +17.3% |
| Volatility | 5.62% 4.53% |
| Average range | 0.21 |
| Strength index | 49.10 |
| Market sensitivity | 0.81 |
| Relative volume | 0.01 |
| Avg Volume | 5.08M |
| Volume | 1,607 |
Compare · Performance
| ABUS | |
|---|---|
| Perf Week | 12.35% |
| Perf Month | -4.28% |
| Perf Quarter | -12.82% |
| Perf Half Y | -3.15% |
| Perf YTD | -14.63% |
| Perf Year | -9.95% |
| Perf 3Y | 129.40% |
| Perf 5Y | 18.34% |
| Perf 10Y | 46.65% |
| Recommendation | 1.00 |
| Target Price | 5.50 |
| Prev Close | 4.03 |
| Price | 4.11 |
| Change % | 1.89% |